<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30370820</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>29</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1557-9077</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>27</Day>                    </PubDate>                </JournalIssue>                <Title>Thyroid : official journal of the American Thyroid Association</Title>                <ISOAbbreviation>Thyroid</ISOAbbreviation>            </Journal>            <ArticleTitle>A Systematic Review and Meta-analysis of Subsequent Malignant Neoplasm Risk after Radioactive Iodine Treatment of Thyroid Cancer.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1089/thy.2018.0244</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The potential risk of subsequent malignant neoplasms (SMNs) after radioactive iodine (RAI) treatment of thyroid cancer (TC), is an important concern.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We updated a systematic review comparing the risk of SMNs in TC patients treated with RAI to TC patients without RAI. We searched six electronic databases (up to March, 2018), supplemented with a hand search. Two reviewers independently screened citations, reviewed full-text papers, and critically appraised/abstracted data. Random effects meta-analyses were conducted using crude data and data statistically adjusted for confounders. The outcomes were any SMN, and specific SMNs for which sufficient data were available.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We examined 3,506 unique electronic search citations and 93 full-text papers. We included 17 studies (3 systematic reviews and 14 original studies). Published knowledge syntheses were limited by inclusion of small numbers of studies, with 2 systematic reviews suggesting an increased risk of any SMN and one meta-analysis suggesting a reduced risk of breast SMN after RAI treatment. In a meta-analysis of crude data, the risk ratio of any SMN in RAI-treated TC patients was 0.98 (95% confidence interval, CI, 0.76, 1.27) (n = 10 studies of 65,539 individuals, heterogeneity Q = 64.26, degrees of freedom [df] 9, p &lt; 0.001, I2 = 85.99). The pooled risk ratio for any SMN, adjusted for confounders, was 1.16 (95% CI 0.97, 1.39) (n = 6 studies, data from at least 11,241 TC patients, Q = 10.86, df 5, p = 0.054, I2 = 53.96). In secondary analyses examining specific SMNs, although relatively rare, the risk of subsequent leukemia was increased but the risk of multiple myeloma was reduced in in RAI-treated TC patients. There was no significant increased relative risk of breast cancer, salivary cancer, and combined hematologic malignancies according to RAI-treatment status.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The body of evidence on whether I-131 treatment of thyroid cancer is associated with the primary outcome of any SMN is highly heterogeneous and complex. More research is needed examining the long-term risk of specific SMNs after I-131 treatment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yu</LastName>                    <ForeName>Chi Yun</ForeName>                    <Initials>CY</Initials>                    <AffiliationInfo>                        <Affiliation>University of Toronto, Medical School, Toronto, Ontario, Canada ; christineyuyu1@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Saeed</LastName>                    <ForeName>Omar</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>University of Toronto, Endocrinology Fellowship, Toronto, Ontario, Canada ; omar.saeed@medportal.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Goldberg</LastName>                    <ForeName>Alyse S</ForeName>                    <Initials>AS</Initials>                    <AffiliationInfo>                        <Affiliation>Sunnybrook Health Sciences Centre, 71545, Toronto, Ontario, Canada ; alysegoldfinger@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Farooq</LastName>                    <ForeName>Shafaq</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>University Health Network, Endocrinology, Toronto, Ontario, Canada ; drshafaqfarooq@hotmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fazelzad</LastName>                    <ForeName>Rouhi</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Princess Margaret Hospital Cancer Centre, 10051, Library and Information Services , 610 University Ave , Princess Margaret Cancer Centre , Toronto, Ontario, Canada , M5G 2M9 ; rouhi.fazelzad@uhn.on.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Goldstein</LastName>                    <ForeName>David P</ForeName>                    <Initials>DP</Initials>                    <AffiliationInfo>                        <Affiliation>University Health Network, Otolaryngology-Head and Neck Surgery , 610 University Ave , Rm 3-952 , Toronto, Ontario, Canada , M5G 2M9 ; david.goldstein@uhn.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsang</LastName>                    <ForeName>Richard W</ForeName>                    <Initials>RW</Initials>                    <AffiliationInfo>                        <Affiliation>Princess Margaret Hospital Cancer Centre, 10051, Radiation Oncology, Toronto, Ontario, Canada ; richard.tsang@uhn.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brierley</LastName>                    <ForeName>James</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Princess Margaret Hospital Cancer Centre, 10051, Radiation Oncology, Toronto, Ontario, Canada ; james.brierley@rmp.uhn.on.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ezzat</LastName>                    <ForeName>Shereen</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Princess Margaret Hospital Cancer Centre, 10051, Endocrine Oncology, Toronto, Ontario, Canada ; Shereen.Ezzat@uhn.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Thabane</LastName>                    <ForeName>Lehana</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>McMaster University, Clinical Health Research Methods, Evidence, and Impact , 50 Charlton Avenue East , 3rd Floor Martha Wing, Room H325 , Biostatistics Unit , Hamilton, Ontario, Canada , L8N 4A6 ; thabanL@mcmaster.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Goldsmith</LastName>                    <ForeName>Charlie H</ForeName>                    <Initials>CH</Initials>                    <AffiliationInfo>                        <Affiliation>GoldStats Consulting, Simon Fraser University and University of British Columbia, McMaster University, Statistics, Toronto, Ontario, Canada ; cgoldsmi@sfu.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sawka</LastName>                    <ForeName>Anna M</ForeName>                    <Initials>AM</Initials>                    <AffiliationInfo>                        <Affiliation>Toronto General Hospital, Endocrinology , 200 Elizabeth Stret , 12 EN-212 , Toronto , Toronto, Ontario, Canada , M5G 2C4 ; Annie.Sawka@uhn.ca.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Thyroid</MedlineTA>            <NlmUniqueID>9104317</NlmUniqueID>            <ISSNLinking>1050-7256</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30370820</ArticleId>            <ArticleId IdType="doi">10.1089/thy.2018.0244</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>